Publications
- Ocrelizumab - long-term efficacy and safety in real-world clinical practice in patients with relapsing-remitting multiple sclerosis2022 | Second Faculty of Medicine
- Ofatumumab - new and different monoclonal anti-CD20 antibody in the treatment of multiple sclerosis2021 | Second Faculty of Medicine
- Low prevalence of neural autoantibodies in perioperative cerebrospinal fluid samples of epilepsy surgery patients: A multicenter prospective study2024 | Central Library of Charles University, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Paraneoplastic or not? Sirtuin-2 in anti-N-methyl-D-aspartate receptor encephalitis2023 | Central Library of Charles University, Second Faculty of Medicine
- Antibody-Negative Autoimmune Encephalitis: A Single-Center Retrospective Analysis2023 | Central Library of Charles University, Second Faculty of Medicine
- IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis2022 | Second Faculty of Medicine
- Management of secondary-progressive multiple sclerosis2022 | Second Faculty of Medicine
- Moderní farmakoterapie v neurologii2021 | Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine, First Faculty of Medicine
- Elevated D-dimer as an immediate response to alemtuzumab treatment2021 | Second Faculty of Medicine
- Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score2021 | Second Faculty of Medicine
Loading network view...